ホーム › 骨髄異形成症候群 › カリフォルニア州 › Baldwin Park
Baldwin Park、CAにおける骨髄異形成症候群の臨床試験
Baldwin Parkとその周辺地域（約30マイル以内）の拠点で、骨髄異形成症候群に関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
被験者募集中第1/2相
- City of Hope - Duarte, Duarte · 4マイル先
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
被験者募集中第3相
- City of Hope - Comprehensive Cancer Center (CCC), Duarte · 4マイル先
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
被験者募集中第3相
- City of Hope, Duarte · 4マイル先
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
被験者募集中第2相
- City of Hope National Medical Center, Duarte · 4マイル先
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
被験者募集中第1相健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
被験者募集中第2相
- GSK Investigational Site, Duarte · 4マイル先
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
被験者募集中
- Beckman Research Institute of City of Hope, Duarte · 4マイル先
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
被験者募集中第1相健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
被験者募集中第2相健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Duarte · 4マイル先
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Study of REM-422 in Patients With AML or Higher Risk MDS
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
他の都市における骨髄異形成症候群の試験
- Houston, TX43件の研究
- New York City, NY21件の研究
- Seattle, WA21件の研究
- Washington, DC20件の研究
- Tampa, FL19件の研究
- Boston, MA19件の研究
- Miami, FL17件の研究
- Durham, NC14件の研究
- Columbus, OH14件の研究
- St. Louis, MO13件の研究
- Atlanta, GA13件の研究
- Chicago, IL13件の研究
Baldwin Parkにおける他の研究
- 乳がん44件の研究
- 急性骨髄性白血病40件の研究
- 大腸癌37件の研究
- 非小細胞肺癌36件の研究
- がん（全種類）34件の研究
- 前立腺がん30件の研究
- 転移性癌30件の研究
- 卵巣がん25件の研究
- 肺がん24件の研究
- 多発性骨髄腫23件の研究
- 胃癌22件の研究
- 急性リンパ性白血病21件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。